Market Cap | ₹861Cr |
ROE | 14.52% |
P/E Ratio(TTM) | 18.67 |
EPS(TTM) | 4.60 |
P/B Ratio | 2.64 |
Dividend Yield | 0.87% |
Industry P/E | 41.14 |
Book Value | 32.53 |
Debt to Equity | 0.03 |
Face Value | 5 |
Parent Organisation | Anuh Pharma |
Managing Director | Mr. Ritesh Bipin Shah |
NSE Symbol | ANUHPHR |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Divi's Laboratories | NA (0.00%) | 70.13 | ||
Neuland Laboratories | NA (0.00%) | 111.47 | ||
Jubilant Pharmova | NA (0.00%) | 37.80 | ||
Acutaas Chemicals | NA (0.00%) | 62.78 |